Alterations in DNA methylation have been proposed as a mechanism for the complex toxicological effects of arsenic. In this study, whole-genome DNA methylation and gene expression changes were evaluated in lungs from female mice exposed for 90 days to 50 ppm arsenate (As) in drinking water. DNA methylation changes were measured using reduced representation bisulfite deep sequencing. Differential methylation was observed in approximately 700 and 1900 start and transcribed regions, respectively. The start regions showed bias toward decreased methylation. No bias was observed in the transcribed region. A comparison of absolute methylation levels in the control animals with treatment-related changes in methylation showed that baseline methylation levels play a role in determining which genes are methylated. Genes with low absolute methylation levels in the start region showed a trend toward increased As-related methylation and decreased expression. Genes with high levels of methylation in the transcribed region showed a trend toward decreased As-related methylation, but no change in expression. No overall correlation between treatment-related changes in methylation and expression was identified. Among genes showing differential methylation in the start region and differential expression, only 57% showed an inverse correlation. The results suggest that differential methylation following As treatment may only play a permissive role in regulating expression. Despite the low correlation, the subset of 17 genes that showed an inverse relationship between As-related methylation and expression included a substantial number that has been demonstrated to play a functional role in cancer-related processes and other effects consistent with arsenic exposure.
Alterations in DNA methylation have been proposed as a mechanism for the complex toxicological effects of arsenic. In this study, whole-genome DNA methylation and gene expression changes were evaluated in lungs from female mice exposed for 90 days to 50 ppm arsenate (As) in drinking water. DNA methylation changes were measured using reduced representation bisulfite deep sequencing. Differential methylation was observed in approximately 700 and 1900 start and transcribed regions, respectively. The start regions showed bias toward decreased methylation. No bias was observed in the transcribed region. A comparison of absolute methylation levels in the control animals with treatment-related changes in methylation showed that baseline methylation levels play a role in determining which genes are methylated. Genes with low absolute methylation levels in the start region showed a trend toward increased As-related methylation and decreased expression. Genes with high levels of methylation in the transcribed region showed a trend toward decreased As-related methylation, but no change in expression. No overall correlation between treatment-related changes in methylation and expression was identified. Among genes showing differential methylation in the start region and differential expression, only 57% showed an inverse correlation. The results suggest that differential methylation following As treatment may only play a permissive role in regulating expression. Despite the low correlation, the subset of 17 genes that showed an inverse relationship between As-related methylation and expression included a substantial number that has been demonstrated to play a functional role in cancer-related processes and other effects consistent with arsenic exposure.
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Arsenic is an abundant naturally occurring element that is present at varying concentrations in most environmental media. Human exposure to arsenic is predominantly through drinking water. Chronic exposure to concentrations on the order of several hundred parts per billion has been associated with an increased incidence of vascular disease, hypertension, diabetes mellitus, and cutaneous and internal cancers (Navas-Acien et al., 2005; Yoshida et al., 2004) . In the lung, an increased incidence of lung cancer, bronchitis, and obstructive or restrictive lung disease has been observed in populations exposed to high levels of arsenic (Guha Mazumder, 2007; Hopenhayn-Rich et al., 1998; Hossain et al., 2005) .
A variety of animal studies have demonstrated an effect of arsenic exposure on the respiratory system. Short-term exposure of pregnant mice to arsenite in drinking water at 85 ppm increased lung tumor incidence in the adult offspring (Waalkes et al., 2003) . High-dose in utero exposure to arsenic also caused lung tumors that were promoted by topical 12-Otetradecanoylphorbol-13-acetate administration (Waalkes et al., 2004) . At low doses (below 100 ppb), in utero and early postnatal exposures to arsenic in mice altered airway reactivity to methacholine challenge (Lantz et al., 2009) . The changes in airway reactivity persisted despite removal of arsenic exposure. Furthermore, arsenic exposure in adult mice at 10 and 100 ppb has also been shown to increase morbidity and virus titers following influenza infection (Kozul et al., 2009a) .
DNA methylation can regulate gene transcription without changes in the sequence of the DNA (Holliday and Pugh, 1975) . Aberrant changes in DNA methylation have been associated with both cancer and noncancer effects. Within the lung, alterations in DNA methylation have been shown to play a role in tumorigenesis (Heller et al., 2010; Jones and Baylin, 2007) , airway inflammation, and other diseases (Adcock et al., 2007) . In the traditional model of the effects of DNA methylation, hypermethylation of CpG islands in the promoters of target genes inhibits the initiation of transcription (Holliday and Pugh, 1975; Riggs, 1975) . However, approximately 40% of human genes do not have traditionally defined CpG islands (Takai and Jones, 2002) . Recent studies have shown a relationship between methylation of non-island CpGs and tissuespecific expression (Eckhardt et al., 2006; Hong et al., 2009) . Apart from the role of non-island CpGs, the studies also demonstrated little overall correlation between methylation and expression (Eckhardt et al., 2006) . In a survey of 873 genes, only 17% were differentially methylated in the 5# untranslated region, and approximately 1/3 of the differentially methylated genes showed an inverse correlation between methylation and transcription (Eckhardt et al., 2006) . The current model incorporates the effects of both island and non-island CpG methylation on transcription and defines a more permissive role for differential methylation in regulating expression, such as maintaining open chromatin conformation.
Alterations in DNA methylation associated with arsenic treatment have been evaluated in cell and animal models (Jensen et al., 2009; Reichard et al., 2007; Xie et al., 2007; Zhao et al., 1997; Zhong and Mass, 2001 ). In the mouse liver, in utero exposure to arsenic did not change global methylation status but appeared to reduce methylation in GC-rich regions (Xie et al., 2007) . Global DNA hypomethylation was observed following long-term arsenic treatment of a rat hepatocyte cell line, and the extent of hypomethylation was correlated with malignant transformation (Zhao et al., 1997) . In a more detailed analysis of arsenic-induced DNA methylation changes in immortalized human urothelial cells, both hyper-and hypomethylation of promoter regions were observed, with hypermethylation being more prevalent (Jensen et al., 2009 ). Methylation changes progressed over time and were correlated with malignant transformation (Jensen et al., 2009) .
Improvements in sequencing and computational technologies have enabled the examination of genome-wide methylation changes using bisulfite sequencing (Meissner et al., 2005 (Meissner et al., , 2008 . In this study, methylation changes in the lungs of female mice exposed to arsenate (As) in drinking water for 90 days were assessed using reduced representation bisulfite deep sequencing. In parallel, gene expression microarray analysis was carried out on the lung samples of treated and control mice. The functional consequences of arsenic-related epigenetic changes were assessed by comparing methylation changes within specific genomic regions with alterations in gene expression.
MATERIALS AND METHODS
Chemicals. Sodium arsenate (96% purity) was obtained from Sigma Chemical Co. (St Louis, MO).
Animals and treatment.
A detailed description of the mice and treatment methods has been reported previously (Kenyon et al., 2008) . Forty-five-day-old female C57BL/6 mice were obtained from Charles River Laboratories (Raleigh, NC) and acclimated for 2 weeks. Mice (n ¼ 5 per group) received 50 ppm arsenic in the form of As in their drinking water for up to 12 weeks. Control mice were given distilled deionized water only. Water consumption was measured throughout the study period and mice were weighed weekly. At the end of the study, mice were killed by exsanguination under CO 2 anesthesia. The lung tissue was harvested immediately, minced in RNAlater (Ambion, Austin, TX), and stored at À70°C. All lung tissues removed from exposed mice appeared grossly normal.
Methylation measurements using reduced representation bisulfite deep sequencing. A portion of the lung tissue frozen in RNAlater was removed from each sample and used to isolate genomic DNA. Tissue from each treatment group was suspended in 1.2 ml cell lysis buffer (10mM NaCl, 10mM Tris-Cl pH 7.8, 2mM EDTA) on ice and homogenized for 2 min (sterile 3-mm steel ball, Mixer Mill MM 301; Retsch, Newtown, PA). After addition of 125 ll 10% SDS solution and 23 ll proteinase K (20 mg/ml; Invitrogen, Carlsbad, CA), the homogenate was incubated at 55°C for 3 h, which was followed by the addition of 13 ll DNase-free RNase A (2 mg/ml; Sigma) and an incubation for 30 min at 37°C. Protein precipitation was carried out by mixing 1340 ll tissue lysate 1:1 with phenol:chloroform:isoamyl alcohol (Invitrogen) in Phase Lock Gel Heavy Tubes (5Prime, Gaithersburg, MD), followed by 15 min centrifugation at 3200 3 g. The 1:1 chloroform extraction of the aqueous phase at 3200 3 g was followed by the addition of 1/40 volume 3M sodium acetate solution and 2 volumes ethanol. Genomic DNA was precipitated at 16,000 3 g and washed with 70% ethanol before resuspension of the air-dried pellet in buffer (10mM Tris, 1mM EDTA pH 7.5). Following resuspension, equal amounts of genomic DNA from the five As-treated animals were pooled together and equal amounts of genomic DNA from the five control animals were pooled together. Five micrograms of pooled genomic DNA from control and treated animals were digested with 400 U MspI (New England Biolabs, Ipswich, MA) in 100 ll at 37°C for 18-24 h, followed by QIAquick purification (Qiagen, Valencia, CA). The end of the digested DNA was repaired, and an adenine was added to the 3# end of the DNA fragments according to the Illumina standard end repair and add_A protocol (Illumina, San Diego, CA). Pre-annealed forked Illumina adaptors containing 5#-methylcytosine instead of cytosine was ligated to both ends of DNA fragments using standard Illumina adaptor ligation protocol (Illumina). Ligated fragments were then separated by 2% agarose gel (Sigma). Two size ranges, 150-175 bp and 175-225 bp (includes adaptor length), were selected and cut from the gel. DNA from gel slices were purified using Qiagen Gel Extraction Kit (Qiagen). The purified DNA was treated with EpiTect Bisulfite Kit (Qiagen) with modification. The bisulfite conversion time was extended to approximately 14 h by adding three cycles of denaturation at 95°C for 5 min, followed by incubation at 60°C for 180 min. The bisulfite-converted DNA was purified using the EpiTect Bisulfite Kit and the protocol for DNA isolated from formaldehyde-fixed, paraffin-embedded tissue samples. The purification protocol was modified by adding the desulfonation buffer to the spin column and incubating for 20 min instead of 15 min at room temperature. The bisulfitetreated DNA was purified a second time with MinElute PCR Purification Kit (Qiagen) and eluted with 15 ll EB buffer. The bisulfite-treated DNA fragments were amplified using PCR and the following reaction: 15 ll of eluted DNA, 5 pmol of Illumina PE PCR primers 1.0 and 2.0, 62.5nM of each dNTP, and 2.5 U of PfuTurbo Cx Hotstart DNA Polymerase (Stratagene Products, Agilent, La Jolla, CA) in a total 50-ll volume. The amplification conditions were as follows: 5 min at 95°C, 30 s at 98°C then 63 (10 s at 98°C, 30 s at 65°C, 30 s at 72°C), followed by 5 min at 72°C. The PCR reaction was purified by MinElute PCR Purification Kit (Qiagen), and final reduced representation bisulfite library was eluted in 15 ll EB buffer. The concentration of the final library was measured using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). The library was sequenced on Illumina GA sequencing instrument according to standard Illumina cluster generation and sequencing protocols. The sequencing reads have been deposited in the National Center for Biotechnology Information Sequence Read Archive (accession no.: SRA012495.5).
Gene expression microarray measurements. Microarray measurements were carried out separately on each of the five animals per treatment group. Total RNA was isolated using Trizol reagent (Invitrogen). The isolated RNA was further purified using RNeasy columns (Qiagen), and the integrity of the RNA was verified spectrophotometrically and with the Agilent 2100 Bioanalyzer (Agilent). Double-stranded complementary DNA (cDNA) was synthesized from 5 lg of total RNA using the One-Cycle cDNA Synthesis Kit (Affymetrix, Santa Clara, CA). Biotin-labeled complementary RNA (cRNA) was transcribed from the cDNA using the GeneChip IVT Labeling Kit Analysis of the reduced representation bisulfite deep sequencing data. The 50-bp high-throughput sequencing reads were aligned against the mm9 Mus musculus reference genome (Build 37; Rhead et al., 2010) using the bisulfite alignment mode of the Novoalign software application (Novocraft Technologies Sdn Bhd, Kuala Lumpur, Malaysia). An alignment threshold of 160 was used. Read coverage for CG residues was extracted via conversion of the aligned sequencing reads to the MAQ analysis pipeline by using the PILEUP tool against a CG masked reference genome . Counts for methylated and unmethylated cytosines were extracted using custom Perl scripts. Genomic annotation of all cytosines with sequence coverage was carried out using the CisGenome software (Ji et al., 2008) .
Although some previous studies have used a percentage scale to represent the extent of DNA methylation (e.g., Cokus et al., 2008) , a log 2 ratio of methylated to unmethylated CpG counts was used in this study after adding one count to both values.
The representation of methylation in this manner allows comparisons at both extremes of the percent scale. For example, the fold difference between 1 and 2% is identical to the fold difference between 98 and 99%. The addition of 1 to the numerator and denominator was carried out to allow log conversion of all ratios.
The start region was defined as 2000 bp upstream of the transcription start site as defined by the Refseq database to 1000 bp downstream of the transcription start site. The transcribed region was defined as 1000 bp downstream of the transcription start site to the transcription end site. The intergenic region was defined as any sequence outside of the start region or transcribed region. Intergenic CpG regions were evaluated for trend-based methylation differences between control and treated samples. A single CpG residue was used as a starting point. A Fisher's exact test was carried out based on the combined number of methylated and unmethylated CpGs within all sequencing reads spanning that location. Following the statistical test, the methylated and unmethylated counts for the next neighboring CpG location was combined with the starting location and the Fisher's exact test was repeated. If the p value from the Fisher's exact test using the combined sequencing counts was equal to or lower than the previous p value, the region was considered to possess a methylation trend. In a similar manner, the following residue was then used to confirm the methylation trend, which resulted in the dynamic extension of the region. The process was repeated until the Fisher's exact test resulted in a higher p value from the previous test. The calculations were carried out in both directions to verify orientation-independent conservation of the methylation trend. Neighboring residues with fluctuating methylation ratios were combined into regions of random methylation trend. To improve the robustness of the approach, the inclusion of one nonconforming residue in a trend region was allowed if the next neighboring residue was able to generate an overall lower p value. The advantage of this approach was to combine residues into trend conserved regions even if no significant treatment-induced change in methylation was detected. The combined methylation counts of each region with random or conserved methylation trend were then subjected to a final Fisher's exact test that assessed their probability of being differentially methylated. The corresponding p values were corrected for false discovery rate (Storey and Tibshirani, 2003) in Partek Genomics Suite (Partek, Inc., St Louis, MO).
Analysis of gene expression microarray data. Affymetrix CEL files were imported at the probe level, normalized using GCRMA (Wu et al., 2004) , and log 2 transformed. A two-sample comparison was carried out using a rank product test as previously described (Breitling and Herzyk, 2005; Kozul et al., 2009b) . For genes with more than one probe set, the probe set with the lowest false discovery rate-corrected p value and corresponding expression change was retained for comparative analysis.
Quantitative reverse transcriptase-PCR confirmation of gene expression changes. Total RNA was isolated using Trizol reagent (Invitrogen). The isolated RNA was further purified using RNeasy columns (Qiagen). The firststrand cDNA was synthesized using the High Capacity RNA-to-cDNA Master Mix reagents (Applied Biosystems, Foster City, CA). Quantitative reverse transcriptase (RT)-PCR was carried out using TaqMan Universal PCR Master Mix (Applied Biosystems) and probe and primer sets from Applied Biosystems and Integrated DNA Technologies (Coralville, IA). The genes were Sema7a (Mm00441361_m1), Glul (Mm00725701_s1), Zkscan14 (PRB.N023322.2.pt. Zkscan14), and Topors (Mm00506480_m1). The Ppia gene (PRB.N008907. 1.pt.Ppia) was used as the normalization control. Ppia has been previously used as an internal control gene (Radonic et al., 2004) , and it was selected for this study because of its low treatment-related variability in the microarray study. DDCt values were calculated relative to Ppia and the vehicle control group. A Student's t-test was used to evaluate the statistical significance of the change in mRNA levels.
RESULTS

CpG Coverage in As-Treated and Control Samples
Approximately 31 million and 25 million sequence reads were generated from the bisulfite-converted genomic DNA in the As-treated and control samples, respectively (Supplementary table 1). More than 70% of the sequence reads aligned to unique genomic locations. Within the sequence reads, a total of 3.1 million CpG residues were covered in the As-treated sample and 3.8 million CpG residues in the control sample (Table 1 ). The intersection of CpG coverage in both treated and control samples contained 1.9 million CpG residues. The locations of each CpG sequence were mapped on the reference genome and assigned to three categories relative to location to the nearest gene: transcription start region, transcribed region, or intergenic region. The majority of the CpG residues that possessed coverage in both treated and control samples was in the start region. It should be noted that CpG residues located in repetitive elements were underrepresented in our analysis because of the short length of the sequencing reads and the requirement for a unique match during sequence alignment.
From a gene-centric view, methylation information was collected for the start region in both As-treated and control samples on 16,119 genes (Table 2) . A similar number of genes contained methylation information in the transcribed region. After removing regions with sequencing coverage of less than 10 reads, the number of genes with CpG coverage for both Astreated and control samples were 13,657 and 13,571 in the start region and transcribed region, respectively. These numbers correspond to approximately 64% of all annotated mouse genes. The incomplete sequencing coverage is primarily because of anchoring the sequencing adaptors to MspI digestion sites. Nonetheless, similar genes were covered between treated and control samples as indicated by the 92% overlap.
The intergenic CpG residues lacked the convenient genebased associations that would allow them to be combined into functionally meaningful regions for the analysis of differential methylation. Because the primary aim of the study was to identify As-related methylation changes, neighboring intergenic CpG residues were combined if methylation differences between control and treated samples followed the same trend (called trend regions). Conversely, neighboring CpG residues were grouped into separate regions if methylation differences fluctuated between control and treated samples (called random regions). Regions were split if neighboring CpG residues were separated by more than 3 kb. The grouping of intergenic CpG residues based on differential methylation trends reduced the total number of individual CpG residues from approximately 650,000 to 112,127 trend regions (Table 3) . Of these trend regions, only 75,199 possessed sequencing coverage of 10 or more reads. A complete list of differentially methylated intergenic regions is provided in Supplementary table 2.
Methylation Levels within Genomic Regions and Changes following As Exposure
For each region (start region, transcribed region, and intergenic region) the frequency of occurrence was plotted as a function of the absolute methylation level (Fig. 1, top) . The frequency histograms revealed distinct distributions of methylation across the different genomic regions. The start region was skewed toward low methylation levels, whereas the transcribed region showed higher methylation. The log 2 methylation ratio of À8 to À5 that contains the majority of the start regions corresponds to a range of 0.4-3% methylation. The distribution of methylation in the translated region peaked with a log 2 methylation ratio between 1 and 5 (66-97%). The intergenic regions also showed high methylation levels.
To examine treatment-related changes in methylation as a function of absolute methylation levels, differences in the control and As-treated frequency histograms for each region were plotted (Fig. 1, bottom) . No dramatic shifts were observed in the distributions of the different genomic regions. However, subtle shifts in methylation levels were observed in the start region. Start regions with a log 2 methylation ratio between À9 and À6 (0.2-1.5%) were increased following As treatment, whereas the start regions with a log 2 methylation ratio between À6 and À4 (1.5-5.9%) exhibited a decrease.
Relationship between Absolute Methylation and Expression Levels
To evaluate the relationship between global methylation and expression, scatter plots were created for absolute methylation levels in the start and transcribed regions compared with expression levels (Fig. 2, top) . Based on the moving average within the start region, a slight biphasic negative trend was observed between absolute methylation and expression. The negative trend began with an average log 2 methylation ratio around À4 (5.9%) and flattened out at a log 2 methylation ratio around À6 (1.5%). On average, genes with higher methylation in the start region possessed lower expression levels, with the effect leveling off among genes with a log 2 methylation ratio of approximately À6 (1.5%). No discernible relationship between absolute methylation in the transcribed region and expression was apparent. Among only the genes showing statistically significant changes in methylation and expression following As treatment, a slight negative trend was observed between absolute methylation in the start region and expression (Fig. 2,  bottom) . No discernible trend was observed between absolute methylation in the transcribed region and expression.
Treatment-Related Methylation and Expression Changes as a Function of Control Methylation and Expression Levels
To assess whether basal methylation and expression status had effects on arsenic-related changes in methylation and expression, values from control animals were used as a surrogate and compared with the moving average of the treatment-related changes in methylation and expression (Fig. 3) . For example, it is possible that methylation related to arsenic treatment may be different for a gene with a low basal methylation level compared with one that is already highly methylated. Within the start region, genes that showed differential expression and that possessed an absolute log 2 methylation level less than À7 (0.8%) in control animals showed a trend in the moving average toward decreased expression (Fig. 3A) . In addition, genes that showed differential methylation and that possessed an absolute log 2 methylation level less than À7 (0.8%) in control animals showed a moving average trend toward increased treatmentrelated methylation (Fig. 3F) . Interestingly, this transition point around À7 corresponded to the peak frequency of the start region methylation level (Fig. 1) . No obvious trends were observed when treatment-related changes in methylation were analyzed as a function of absolute expression levels. As expected, among the significantly differentially expressed genes, genes with lower absolute expression levels in control animals showed a moving average trend toward increased expression and highly expressed genes showed a trend toward decreased expression (Fig. 3C ). This trend was not observed in genes with significant treatment-related changes in methylation (Fig. 3D) .
Within the transcribed region, genes that showed differential expression and that possessed an absolute log 2 methylation FIG. 1. Frequency histograms of absolute DNA methylation levels within the start, transcribed, and intergenic regions. The absolute DNA methylation levels are expressed as log 2 methylation ratio to provide symmetry at both ends of the distribution (see ''Materials and Methods'' section). The frequency histograms are broken out based on As treatment and vehicle control (H 2 O). The treatment-related change in frequency is shown below the histograms. level greater than 3 (89%) in control animals did not show a trend in treatment-related expression (Fig. 4A) . However, genes that showed differential methylation and an absolute log 2 methylation level greater than 3 (89%) in control animals showed a trend toward decreased methylation following As treatment (Fig. 4F ). Similar to observations for the start region, the transition point of 3 corresponded to the peak frequency of the transcribed region methylation level (Fig. 1) . Among the significantly differentially expressed genes, those with lower absolute expression levels in control animals showed a trend toward increased expression and highly expressed genes showed a trend toward decreased expression (Fig. 4C ). This trend was not observed in genes with significant treatmentrelated changes in methylation (Fig. 4D) . Finally, among genes with an absolute log 2 expression level greater than 12 in control animals, there was a trend toward treatment-related increases in intragenic methylation (Fig. 4G) . A complete breakdown of methylation and expression measurements in the start and transcribed region is provided in Supplementary table 3.
Relationship between Treatment-Related Changes in Methylation and Expression
More than 12,000 genes had methylation coverage and expression measurements in both the start and the transcribed regions (Table 4 ). The magnitude of the treatment-related changes in expression was not large. However, both the magnitude and the genes themselves were similar to that observed in the mouse lung following exposure to 100 ppb Scatter plots were created for treatment-related changes in methylation and expression. Among all genes, no overall correlation was observed in either the start region or the transcribed region (start region, r ¼ À0.011, p ¼ 0.218; transcribed region, r ¼ 0.011, p ¼ 0.222; Fig. 5, top) . Among only the genes showing significant changes in methylation and expression, no significant correlation was observed in either the start region or the transcribed region (start region, r ¼ À0.168, p ¼ 0.375; transcribed region, r ¼ À0.023, p ¼ 0.794; Fig. 5 , bottom). However, there was a better correlation observed in the start region among genes showing significant changes in methylation and expression than that observed for all genes or for the transcribed region. The lower number of overlapping genes showing changes in expression and methylation limited the statistical power to detect a significant correlation.
Within the start region, As treatment resulted in a greater percentage of genes showing hypomethylation. Specifically, 63% of the genes showing significant treatment-related changes in methylation in the start region and 73% of the genes showing treatment-related changes in methylation in the start region and differential expression were hypomethylated. Within the transcribed region, there was no bias toward hypo-or hypermethylation, with 51 and 53% of the genes showing decreased methylation among genes with significant treatment-related changes in methylation and significant treatment-related changes in methylation and expression, respectively.
Biological Processes among Genes Showing TreatmentRelated Changes in Methylation and Expression
Genes showing the traditional inverse correlation between the treatment-related changes in methylation and expression were further investigated for their potential role in arsenic toxicity (Fig. 5, red boxes) . Among these genes, a substantial number has been demonstrated to play a functional role in cancer-related processes and other effects associated with arsenic exposure (Table 5 ). The direction of the expression change observed in our study was largely consistent with the direction associated with the biological effects.
Quantitative RT-PCR Confirmation of Expression Changes
A subset of four genes showing treatment-related differential methylation in the start region and changes in expression were validated using quantitative RT-PCR. The genes were among those showing a treatment-related inverse relationship between methylation in the start region and expression in the microarray studies. One gene, Topors, showed increased methylation and decreased expression. Three genes, Sema7a, Glul, and Zkscan14, showed decreased methylation and increased expression. The quantitative RT-PCR confirmed the gene expression changes observed by microarray (Fig. 6 ).
DISCUSSION
Alterations in DNA methylation have been proposed as a mechanism for the complex toxicological effects of arsenic. Multiple studies have associated the extent of arsenic-related methylation changes with malignant transformation, but most studies have only measured gross methylation changes (Zhao et al., 1997) . The limitations of these studies reflect the technological limitations that existed in measuring DNA methylation changes at the level of the genome. The development of deep sequencing technologies has enabled bisulfite genomic sequencing of millions of reads. The methylation status of specific genomic regions or even individual CpG residues can be measured with adequate sequencing depth. When integrated with gene expression microarray measurements, the functional effects of methylation changes from arsenic exposure can be explored on a genome-wide basis.
In this study, whole-genome DNA methylation and gene expression changes were evaluated in lungs from female mice exposed for 90 days to 50 ppm As in drinking water. DNA methylation changes were measured using reduced representation bisulfite deep sequencing. On a genome-wide level, no dramatic change in DNA methylation was observed in the Relative to the union.
METHYLATION AND EXPRESSION IN ARSENIC EXPOSURE
lungs of mice exposed to this high concentration of As. When analyzed statistically, differential methylation was observed in 753 and 1,859 start and transcribed regions, respectively. Within the start region, there was a bias toward decreased methylation, and the bias was absent in the transcribed region of the genes. Although the biological significance of this bias toward decreased methylation is unknown, it demonstrates a targeted directional disruption of the methylation state in lungs of exposed mice. Because the decreased methylation was observed only in the start region, this observation runs counter to both the global hypomethylation seen by Zhao et al ( 1997) and the slight bias toward promoter hypermethylation reported by Jensen et al. (2009) . Notably, both methylation measurement techniques and the tissues examined were different among the studies. First, Zhao et al. (1997) used a rat liver cell line and measured global methylation that included both repetitive and nonrepetitive DNA. Second, Jensen et al. (2009) used a human urothelial cell line and measured CpG island methylation in promoter regions using microarrays. Our study examined the mouse lung using methylation measurements that were biased against repetitive regions.
The absolute methylation and expression levels in the control animals were used as a surrogate for assessing the effects of basal methylation and expression status on treatment-related changes in methylation and expression. Genes with an absolute methylation level less than 0.8% in the start region of control animals showed a trend toward increased treatment-related methylation and decreased expression. Genes with higher methylation levels in the start region of control animals did not show a consistent trend. Similarly, within the transcribed region, genes that possessed an absolute methylation level greater than 89% in control animals showed a trend toward decreased treatment-related methylation, but no trend in expression. An interesting aspect of these observations was that the transition points of 0.8 and 89% methylation in the start and transcribed regions, respectively, corresponded to the peak frequencies associated with the methylation level for each region. This observation indicates that baseline methylation levels play a role in determining which genes are susceptible to Asrelated methylation and that the role can be shifted by relatively small changes in methylation. Conceptually, DNA methylation in the start region may have an impact on gene transcription over a relatively narrow methylation range. For most genes, a cell would also need to maintain DNA methylation levels within that range to allow epigenetic regulation. This balancing act would also make these genes susceptible to epigenetic alterations by chemical agents. For the transcribed region, very high methylation levels have been suggested to reduce transcription by inhibiting transcriptional elongation (Zilberman et al., 2007) . Therefore, the cell would also need to maintain the methylation level below a certain limit in the transcribed region to allow efficient transcription.
The transcriptional silencing of specific genes through methylation of upstream promoter regions is important in neoplastic transformation (Jones and Baylin, 2007) . In general, studies on methylation-induced gene silencing have focused on specific genes or subsets of genes and few studies have examined the overall correlation between changes in methylation and expression on a large scale. In one study, the correlation between tissue-specific differential methylation and expression was examined for a subset of 43 genes (Eckhardt et al., 2006) . The results in the study showed no correlation between methylation and expression for 63% of the genes and an inverse correlation for 37% of the genes (Eckhardt et al., 2006) . In our study, among genes showing differential methylation in the start region, 55% showed an inverse correlation. The percentage showing an inverse correlation was similar (57%) among genes showing differential methylation in the start region and differential expression. The overall correlation among the differentially methylated genes was also not statistically significant. The results suggest that differential methylation following As treatment may only play a permissive role in regulating expression. Despite the low overall correlation, the biological function of the genes showing an inverse correlation between treatmentrelated changes in methylation and expression was examined. A substantial number of the genes showing the inverse correlation play a functional role in cancer-related processes and other noncancer effects consistent with arsenic toxicity. With respect to noncancer effects, Sema7a, Glul, and Tgm1 showed increased expression in our study with a corresponding decrease in methylation. Sema7a has been shown to play a critical role in transforming growth factor-b1-induced lung fibrosis, myofibroblast hyperplasia, alveolar remodeling, and apoptosis (Kang et al., 2007) . In bleomycin-induced pulmonary fibrosis, Sema7a deficiency reduced collagen accumulation by over 90% (Kang et al., 2007) . Similarly, increased expression of Glul has been observed in progressive idiopathic pulmonary fibrosis (Boon et al., 2009) . The increased expression of Sema7a and Glul are consistent with the increased obstructive and restrictive lung disease observed in arsenic-exposed human populations (Guha Mazumder, 2007) .
Tgm1 is an enzyme that adds alkyl group to a glutamine residue of a protein leading to cross-linking of proteins and catenation of polyamines. Tgm1 has been shown to cross-link cornified envelope proteins involvarin and loricrin during epidermal differentiation. Tgm1 also plays a role in microvascular endothelial barrier function whereby the barrier becomes more resistant to compromising stimuli with increasing Tgm1 expression (Aeschlimann and Thomazy, 2000) . The increased expression of Tgm1 in our study and its functions are consistent with the peripheral vascular disease observed following arsenic exposure (Navas-Acien et al., 2005; Yoshida et al., 2004) .
For cancer, multiple genes were identified in the subset showing an inverse correlation between methylation and expression. The expression of Pik3r5, Snai1, Tasp1, Myst1, and Tbx3 was increased in our study with a corresponding decrease in methylation. Pik3r5 overexpression confers protection against ultraviolet-induced apoptosis (Johnson et al., 2007) and has co-oncogenic properties (Murga et al., 1998;  Reverter et al., 2008; Uren et al., 2008) . Snai1 regulates the epithelial-mesenchymal transition and has been positively correlated with cancer progression (Jin et al., 2010; Tseng et al., 2010) . Overexpression of Tasp1 occurs in multiple cancer cell lines, and cells lacking Tasp1 are resistant to oncogenic transformation (Takeda et al., 2006) . The overexpression of Myst1 increases cellular proliferation, oncogenic transformation, and tumor growth (Gupta et al., 2008) . Interestingly, decreased expression of Myst1 increases sensitivity of human urothelial cells to arsenic toxicity (Jo et al., 2009) . Therefore, upregulation of Myst1 in our study may be an adaptive response to reduce toxicity. Finally, Tbx3 is a transcriptional repressor that inhibits cellular senescence via interaction with p19ARF-Mdm2-p53 pathway (Brummelkamp et al., 2002) . Overexpression of Tbx3 immortalizes mouse embryo fibroblasts . For each of these genes, the increase in expression is consistent with the increased lung tumors observed with arsenic exposure.
In contrast to the majority of genes related to cancer, the expression of Ank3 and Topors was decreased in our study with a corresponding increase in methylation. The reduced expression of Ank3 has been part of an 11-gene signature of negative cancer treatment outcome (Glinsky et al., 2005) . Topors binds topoisomerase 1 and p53 and has been identified as a tumor suppressor with involvement with cell growth and chromatin remodeling (Saleem et al., 2004) . For both of these genes, the decrease in expression is consistent with the increased lung tumors observed with arsenic exposure.
In summary, this study characterized the genome-wide changes of DNA methylation and gene expression in mouse lung following 90-day As exposure. The results identified several key aspects of methylation and expression as they relate to arsenic toxicity. First, baseline methylation levels play a role in determining which genes are methylated. Genes with a low absolute methylation level in the start region showed a trend toward increased As-related methylation and decreased expression. Genes with a high level of methylation in the transcribed regions showed a trend toward decreased Asrelated methylation, but no change in expression. Second, little overall correlation exists between treatment-related changes in methylation and expression. The results suggest that differential methylation following As treatment may only play a permissive role in regulating expression. Finally, the genes that did show the expected inverse correlation between methylation and expression were closely related to the cancer and noncancer effects of arsenic exposure. Given the proposed role for DNA methylation in arsenic toxicity, these genes and pathways represent new candidates for further understanding the underlying mechanism.
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